Last10K.com

Trovagene, Inc. (TROV) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Trovagene, Inc.

CIK: 1213037 Ticker: TROV

View differences made from one to another to evaluate Trovagene, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Trovagene, Inc..

Continue

Assess how Trovagene, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Trovagene, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Trovagene, Inc. provided additional information to their SEC Filing as exhibits

Ticker: TROV
CIK: 1213037
Form Type: 8-K Corporate News
Accession Number: 0001193125-18-306478
Submitted to the SEC: Wed Oct 24 2018 5:07:11 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Wednesday, October 24, 2018
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Other Events
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/trov/0001193125-18-306478.htm